Therapy for pulmonary arterial hypertension due to congenital heart disease and Down's syndrome

International Journal of Cardiology

Volumn 164, Issue 3, 2013, Pages 323-326

  D'Alto, Michele ^a   Romeo, Emanuele ^a   Argiento, Paola ^a   D'Andrea, Antonello ^a   Sarubbi, Berardo ^a   Correra, Anna ^a   Scognamiglio, Giancarlo ^a   Papa, Silvia ^b   Bossone, Eduardo ^c   Calabrò, Raffaele ^a   Vizza, Carmine D ^b   Russo, Maria G ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c Cava de Tirreni and Amalfi Coast Hospital ASL Salerno 1   (Italy)

Author keywords

Congenital heart disease; Down's syndrome; Pulmonary arterial hypertension

Indexed keywords

BOSENTAN;

ADULT; ARTICLE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; COMPUTER ASSISTED TOMOGRAPHY; CONGENITAL HEART DISEASE; CONTROLLED STUDY; DEATH; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DOWN SYNDROME; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EXERCISE TOLERANCE; FEMALE; HEART CATHETERIZATION; HEART HEMODYNAMICS; HUMAN; LABORATORY TEST; LONG TERM CARE; LUNG FLOW VOLUME CURVE; LUNG HEMODYNAMICS; LUNG VASCULAR RESISTANCE; MAJOR CLINICAL STUDY; MALE; OXYGEN SATURATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY HYPERTENSION; SIDE EFFECT; UNSPECIFIED SIDE EFFECT; WORLD HEALTH ORGANIZATION; AMINOTRANSFERASE BLOOD LEVEL; ATRIOVENTRICULAR CANAL; CONTROLLED CLINICAL TRIAL; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG FATALITY; HEART ATRIUM SEPTUM DEFECT; HEART SINGLE VENTRICLE; HEART VENTRICLE SEPTUM DEFECT; LUNG BLOOD FLOW; OPEN STUDY; PATENT DUCTUS ARTERIOSUS; TREATMENT DURATION; WALKING;

ADMINISTRATION, ORAL; ADULT; ANTIHYPERTENSIVE AGENTS; DOWN SYNDROME; EXERCISE TOLERANCE; FEMALE; FOLLOW-UP STUDIES; HEART DEFECTS, CONGENITAL; HEMODYNAMICS; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SULFONAMIDES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84884211344     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2011.07.009     Document Type: Article

References (38)

1. J.K. Morris, and E. Alberman Trends in Down's syndrome live births and antenatal diagnoses in England and Wales from 1989 to 2008: analysis of data from the National Down Syndrome Cytogenetic Register BMJ 339 2009 b3794
2. S.B. Freeman, L.H. Bean, and E.G. Allen Ethnicity, sex, and the incidence of congenital heart defects: a report from the National Down Syndrome Project Genet Med 10 2008 173 180
3. E.G. Jacobs, M.P. Leung, and J. Karlberg Distribution of symptomatic congenital heart disease in Hong Kong Pediatr Cardiol 21 2000 148 157
4. O. Jaiyesimi, and V. Baichoo Cardiovascular malformations in Omani Arab children with Down's syndrome Cardiol Young 17 2007 166 171
5. K. Suzuki, S. Yamaki, and S. Mimori Pulmonary vascular disease in Down's syndrome with complete atrioventricular septal defect Am J Cardiol 86 2000 434 437
6. C.P. Torfs, and R.E. Christianson Anomalies in Down syndrome individuals in a large population-based registry Am J Med Genet 77 1998 431 438
7. A.A. Wahab, A. Bener, A.L. Sandridge, and G.F. Hoffmann The pattern of Down syndrome among children in Qatar: a population-based study Birth Defects Res A Clin Mol Teratol 76 2006 609 612
8. M.E. Weijerman, A.M. van Furth, and M.D. van der Mooren Prevalence of congenital heart defects and persistent pulmonary hypertension of the neonate with Down syndrome Eur J Pediatr 169 2010 1195 1199
9. R.D. Rowe, and I.A. Uchida Cardiac malformation in mongolism: a prospective study of 184 mongoloid children Am J Med 31 1961 726 735
10. T.P. Chi, and J. Krovetz The pulmonary vascular bed in children with Down syndrome J Pediatr 86 1975 533 538
11. P. Soudon, M. Stijns, M. Tremouroux-Wattiez, and A. Vliers Precocity of pulmonary vascular obstruction of Down's syndrome Eur J Cardiol 2 1975 473 476
12. M. Sungur, B. Ocal, D. Oouz, S. Karademir, C. Karakurt, and F. Senocak Plasma endothelin-1 and nitrate levels in Down's syndrome with complete atrioventricular septal defect-associated pulmonary hypertension: a comparison with non-Down's syndrome children Eur J Pediatr 168 5 2009 593 597
13. K. Kageyama, S. Hashimoto, Y. Nakajima, N. Shime, and S. Hashimoto The change of plasma endothelin-1 levels before and after surgery with or without Down syndrome Paediatr Anaesth 17 2007 1071 1077
14. H. Fukushima, K. Kosaki, and R. Sato Mechanisms underlying early development of pulmonary vascular obstructive disease in Down syndrome: an imbalance in biosynthesis of thromboxane A2 and prostacyclin Am J Med Genet A 152 2010 1919 1924
15. C.L. Cua, L.K. Rogers, and L.G. Chicoine Down syndrome patients with pulmonary hypertension have elevated plasma levels of asymmetric dimethylarginine Eur J Pediatr 170 2011 859 863
16. G.P. Diller, S. Van Eijl, and D.O. Okonko Circulating endothelial progenitor cells in patients with Eisenmenger syndrome and idiopathic pulmonary arterial hypertension Circulation 117 2008 3020 3030
17. B.C. Cannon, T.F. Feltes, J.K. Fraley, R.G. Grifka, E.M. Riddle, and J.P. Kovalchin Nitric oxide in the evaluation of congenital heart disease with pulmonary hypertension: factors related to nitric oxide response Pediatr Cardiol 26 2005 565 569
18. M. Cappelli-Bigazzi, G. Santoro, and C. Battaglia Endothelial cell function in patients with Down's syndrome Am J Cardiol 94 2004 392 395
19. N. Galiè, M. Beghetti, and M.A. Gatzoulis Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study Circulation 114 2006 48 54
20. M.A. Gatzoulis, M. Beghetti, and N. Galiè Longer-term bosentan therapy improves functional capacity in Eisenmenger syndrome: results of the BREATHE-5 open-label extension study Int J Cardiol 127 2008 27 32
21. O. Sitbon, M. Beghetti, and J. Petit Bosentan for the treatment of pulmonary arterial hypertension associated with congenital heart defects Eur J Clin Invest 36 2006 25 31
22. R.L. Benza, B.K. Rayburn, and J.A. Tallaj Efficacy of bosentan in a small cohort of adult patients with pulmonary arterial hypertension related to congenital heart disease Chest 129 2006 1009 1015
23. S.C. Apostolopoulou, A. Manginas, D.V. Cokkinos, and S. Rammos Long-term oral bosentan treatment in patients with pulmonary arterial hypertension related to congenital heart disease: a 2-year study Heart 93 2007 350 354
24. M. D'Alto, C.D. Vizza, and E. Romeo Long term effects of bosentan treatment in adult patients with pulmonary arterial hypertension related to congenital heart disease (Eisenmenger physiology): safety, tolerability, clinical, and haemodynamic effect Heart 93 2007 621 625
25. M.G. Duffels, J.C. Vis, and R.L. van Loon Down patients with Eisenmenger syndrome: is bosentan treatment an option? Int J Cardiol 134 2009 378 383
26. M.G. Duffels, J.C. Vis, and R.L. van Loon Effect of bosentan on exercise capacity and quality of life in adults with pulmonary arterial hypertension associated with congenital heart disease with and without Down's syndrome Am J Cardiol 103 2009 1309 1315
27. N. Galiè, A. Torbicki, and R. Barst Guidelines on diagnosis and treatment of pulmonary arterial hypertension Eur Heart J 25 2004 2243 2278
28. N. Galiè, M.M. Hoeper, and M. Humbert Guidelines for the diagnosis and treatment of pulmonary hypertension Eur Heart J 30 2009 2493 2537
29. P.L. Enright, and D.L. Sherrill Reference equations for the six-minute walk in healthy adults Am J Respir Crit Care Med 158 1998 1384 1387
30. G.H. Guyatt, M.J. Sullivan, and P.J. Thompson The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure Can Med Assoc J 132 1985 919 923
31. W. Grossman Clinical measurement of vascular resistance and assessment of vasodilator drugs W. Grossman, Cardiac Catheterization and Angiography 1991 Lea and Febiger Philadelphia, PA 143 151
32. T.P. Cooney, and W.M. Thurlbeck Pulmonary hypoplasia in Down's syndrome N Engl J Med 307 1982 1170 1173
33. S. Clapp, B.L. Perry, and Z.Q. Farooki Down's syndrome, complete atrioventricular canal, and pulmonary vascular obstructive disease J Thorac Cardiovasc Surg 100 1990 115 121
34. J.F. Lefaivre, S.R. Cohen, and F.D. Burstein Down syndrome: identification and surgical management of obstructive sleep apnea Plast Reconstr Surg 99 1997 629 637
35. T.W. Rowland, L.G. Nordstrom, M.S. Bean, and H. Burkhardt Chronic upper airway obstruction and pulmonary hypertension in Down's syndrome Am J Dis Child 135 1981 1050 1052
36. C.L. Cua, A. Blankenship, A.L. North, J. Hayes, and L.D. Nelin Increased incidence of idiopathic persistent pulmonary hypertension in Down syndrome neonates Pediatr Cardiol 28 2007 250 254
37. C. Frescura, G. Thiene, and M. Giulia Gagliardi Is lung biopsy useful for surgical decision making in congenital heart disease? Eur J Cardiothorac Surg 5 1991 118 122
38. R.N. Channick, G. Simonneau, and O. Sitbon Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study Lancet 358 2001 1119 1123